{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:08:32Z","timestamp":1768442912910,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T00:00:00Z","timestamp":1488931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.leukres.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T02:17:29Z","timestamp":1489025849000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"57","author":[{"given":"Raffaele","family":"Frazzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariaelena","family":"Pistoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ione","family":"Tamagnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Valli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Braglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Merli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.02.012_bib0005","series-title":"SEER Stat Fact Sheets: Non-Hodgkin Lymphoma","author":"Lymphoma, S. S. F. S. N.-H","year":"2017"},{"issue":"20","key":"10.1016\/j.leukres.2017.02.012_bib0010","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2017.02.012_bib0015","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2017.02.012_bib0020","series-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"Cancer, I. A. f. R. o","year":"2008"},{"key":"10.1016\/j.leukres.2017.02.012_bib0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pharmthera.2015.03.003","article-title":"Epigenomes as therapeutic targets","volume":"151","author":"Hamm","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.leukres.2017.02.012_bib0030","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood-2014-08-596247","article-title":"DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features","volume":"125","author":"Arribas","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2017.02.012_bib0035","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/modpathol.2009.49","article-title":"SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer","volume":"22","author":"Nosho","year":"2009","journal-title":"Mod. Pathol."},{"issue":"10","key":"10.1016\/j.leukres.2017.02.012_bib0040","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1087057111422103","article-title":"Sirtuin 1 (SIRT1): the misunderstood HDAC","volume":"16","author":"Stunkel","year":"2011","journal-title":"J. Biomol. Screen."},{"issue":"4","key":"10.1016\/j.leukres.2017.02.012_bib0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbrc.2015.04.119","article-title":"SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1alpha (HIF-1alpha) via direct interactions during hypoxia","volume":"462","author":"Joo","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"24","key":"10.1016\/j.leukres.2017.02.012_bib0050","doi-asserted-by":"crossref","first-page":"20578","DOI":"10.18632\/oncotarget.3987","article-title":"Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.leukres.2017.02.012_bib0055","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/gt.2015.39","article-title":"Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc","volume":"22","author":"Liu","year":"2015","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.leukres.2017.02.012_bib0060","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.3390\/ijms15034977","article-title":"The multiple mechanisms of cell death triggered by resveratrol in lymphoma and leukemia","volume":"15","author":"Frazzi","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.leukres.2017.02.012_bib0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ijc.27748","article-title":"Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation","volume":"132","author":"Frazzi","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.leukres.2017.02.012_bib0070","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/PAS.0b013e31816b6478","article-title":"SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma","volume":"32","author":"Jang","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.leukres.2017.02.012_bib0075","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4161\/cc.27523","article-title":"SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis","volume":"13","author":"Nihal","year":"2014","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.leukres.2017.02.012_bib0080","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2005.08.011","article-title":"Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses","volume":"123","author":"Chen","year":"2005","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.leukres.2017.02.012_bib0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molmed.2014.03.001","article-title":"Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis","volume":"20","author":"Hatzi","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"14","key":"10.1016\/j.leukres.2017.02.012_bib0090","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1158\/0008-5472.CAN-12-0667","article-title":"miR-103\/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4","volume":"72","author":"Chen","year":"2012","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.leukres.2017.02.012_bib0095","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1182\/blood-2012-01-403154","article-title":"Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma","volume":"119","author":"Cubedo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.02.012_bib0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-8722-5-12","article-title":"Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases","volume":"5","author":"Gelsi-Boyer","year":"2012","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2017.02.012_bib0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4161\/auto.2.2.2459","article-title":"DAPk protein family and cancer","volume":"2","author":"Gozuacik","year":"2006","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.leukres.2017.02.012_bib0110","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2009-12-256446","article-title":"KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma","volume":"116","author":"Guan","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2017.02.012_bib0115","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3109\/10428194.2012.753445","article-title":"High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature","volume":"54","author":"Herold","year":"2013","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2017.02.012_bib0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12032-012-0441-3","article-title":"Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma","volume":"30","author":"Krajnovic","year":"2013","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2017.02.012_bib0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/gcc.22139","article-title":"Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia","volume":"53","author":"Ronchetti","year":"2014","journal-title":"Genes Chromosom. Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2017.02.012_bib0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.02.012_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1751-0473-9-11","article-title":"Methylation plotter: a web tool for dynamic visualization of DNA methylation data","volume":"9","author":"Mallona","year":"2014","journal-title":"Source Code Biol. Med."},{"issue":"2","key":"10.1016\/j.leukres.2017.02.012_bib0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12308-008-0008-6","article-title":"Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma","volume":"1","author":"Stocklein","year":"2008","journal-title":"J. Hematopathol."},{"issue":"15","key":"10.1016\/j.leukres.2017.02.012_bib0145","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Lenz","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.leukres.2017.02.012_bib0150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jmoldx.2014.03.003","article-title":"Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker","volume":"16","author":"Giachelia","year":"2014","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.leukres.2017.02.012_bib0155","doi-asserted-by":"crossref","first-page":"11345","DOI":"10.1038\/srep11345","article-title":"Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells","volume":"5","author":"Kozako","year":"2015","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.leukres.2017.02.012_bib0160","doi-asserted-by":"crossref","first-page":"e104249","DOI":"10.1371\/journal.pone.0104249","article-title":"A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma","volume":"9","author":"Bethge","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.leukres.2017.02.012_bib0165","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbrc.2012.04.026","article-title":"Molecular dissection of the interaction between HIC1 and SIRT1","volume":"421","author":"Dehennaut","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.leukres.2017.02.012_bib0170","doi-asserted-by":"crossref","first-page":"10254","DOI":"10.1074\/jbc.M112.421610","article-title":"DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair","volume":"288","author":"Dehennaut","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.leukres.2017.02.012_bib0175","doi-asserted-by":"crossref","first-page":"35866","DOI":"10.18632\/oncotarget.5482","article-title":"Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ERalpha status","volume":"6","author":"Chin","year":"2015","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.leukres.2017.02.012_bib0180","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.18632\/oncotarget.2394","article-title":"Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma","volume":"5","author":"Kristensen","year":"2014","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.leukres.2017.02.012_bib0185","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","article-title":"Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy","volume":"128","author":"Jurinovic","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2017.02.012_bib0190","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T10:04:12Z","timestamp":1568887452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617300681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":38,"alternative-id":["S0145212617300681"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.02.012","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}